Boykin v. Genzyme Therapeutic Products, LP, et al
| CHARLES BOYKIN |
| GENZYME THERAPEUTIC PRODUCTS, PAUL BEAUSOLEIL and GENZYME THERAPEUTIC PRODUCTS, LP |
| 23-1667 |
| August 17, 2023 |
| U.S. Court of Appeals, First Circuit |
| Employment |
Opinions
We have the following opinions for this case:
| Description |
|---|
 Boykin v. Genzyme Therapeutic Products, LP
|
Docket Report
RSS Track this Docket
This docket was last retrieved on October 2, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
ORDER granting motion to extend time to file brief and appendix filed by Appellant Charles Boykin. Brief and Appendix due October 24, 2023 for appellant Charles Boykin. [23-1667] (AL) [Entered: 10/02/2023 10:34 AM]
|
| ASSENTED TO MOTION to extend time to file brief and appendix filed by Appellant Charles Boykin. Served on 09/29/2023. [23-1667] (MJN) [Entered: 09/29/2023 03:39 PM] |
| NOTICE issued. The following attorney has failed to register for an appellate ECF account and will no longer receive notice of court issued documents in this case: Lauren E. DiGiovine for Genzyme Therapeutic Products, LP and Paul Beausoleil. [23-1667] (AL) [Entered: 09/20/2023 11:43 AM] |
| NOTICE issued. After 09/18/2023, the following attorney will no longer receive notice of court issued documents in this case unless she registers for an appellate ECF account: Lauren E. DiGiovine for Genzyme Therapeutic Products, LP and Paul Beausoleil. [23-1667] (AL) [Entered: 08/31/2023 03:35 PM] |
| BRIEFING schedule set. Brief and Appendix due 10/10/2023 for appellant Charles Boykin. Pursuant to F.R.A.P. 31(a), appellee's brief will be due 30 days following service of appellant's brief and appellant's reply brief will be due 21 days following service of appellee's brief. [23-1667] (AL) [Entered: 08/31/2023 03:19 PM] |
| DOCKETING statement filed by Appellant Charles Boykin. Served on 08/29/2023. [23-1667] (MJN) [Entered: 08/29/2023 11:54 AM] |
| NOTICE of appearance on behalf of Appellant Charles Boykin filed by Attorney Mitchell J. Notis. Served on 08/29/2023. [23-1667] (MJN) [Entered: 08/29/2023 11:15 AM] |
| TRANSCRIPT report/order form filed by Appellant Charles Boykin indicating transcripts are not necessary for this appeal. Served on 08/29/2023. [23-1667] (MJN) [Entered: 08/29/2023 11:33 AM] |
| NOTICE of appearance on behalf of Appellees Paul Beausoleil and Genzyme Therapeutic Products filed by Attorney Christopher B. Kaczmarek. Served on 08/18/2023. [23-1667] (CBK) [Entered: 08/18/2023 01:03 PM] |
| CIVIL CASE docketed. Notice of appeal (doc. #47) filed by Appellant Charles Boykin. Docketing Statement due 08/31/2023. Appearance form due 08/31/2023. [23-1667] (AL) [Entered: 08/17/2023 03:26 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
